JESSICA KANDYBE: Open Payments
NPI 1487255816 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 32 payments from 12 companies in 2025. Trend: 2023 $1,367 · 2024 $1,390 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $250 |
| Boston Scientific Corporation | 3 | $158 |
| Actelion Pharmaceuticals US, Inc. | 2 | $143 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $134 |
| BridgeBio Pharma, Inc. | 3 | $122 |
| Amgen Inc. | 1 | $118 |
| Gilead Sciences, Inc. | 1 | $109 |
| E.R. Squibb & Sons, L.L.C. | 1 | $109 |
| Alnylam Pharmaceuticals Inc. | 1 | $101 |
| Merck Sharp & Dohme LLC | 2 | $45 |
Products named: Kerendia, WATCHMAN FLX, LifeVest, UPTRAVI, Attruby, TAVNEOS, Epclusa, CAMZYOS.
Industry payments across CA — which companies pay providers there.
